ZEO ScientifiX Expands into Georgia Tennessee
Analysis based on 6 articles · First reported Sep 15, 2026 · Last updated Sep 15, 2026
The announcement is a small-cap, single-company expansion news item with negligible broad market impact, though it may modestly support sentiment toward regenerative medicine and biotechnology names as more U.S. states adopt enabling frameworks. For ZEO ScientifiX specifically, the expansion could improve its growth narrative and provider reach, but near-term revenue effects remain uncertain and the stock is thinly traded on the OTCQB.
ZEO ScientifiX, Inc. (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on regenerative biologics, announced on September 15, 2026 its planned expansion into Georgia and United States — Tennessee. The move follows the recent enactment of state laws establishing frameworks for certain stem cell and regenerative medicine therapies: Georgia House Bill 1275, signed into law on May 11, 2026, and United States — Tennessee House Bill 2246, signed into law on May 19, 2026. These laws set state-level requirements covering product sourcing and documentation, patient disclosures and informed consent, professional scope of practice, and safety oversight. United States — Tennessee's framework expressly includes certain exosome-based regenerative products within its definition of regenerative medicine therapy when statutory product and manufacturing criteria are met. The state laws do not constitute approval by the U.S. United States — Food and Drug Administration and do not displace applicable federal law. ZEO ScientifiX plans to broaden its commercial and provider-support presence in both states, building on its existing work with healthcare professionals in United States — Florida under that state's 2025 law. The company intends to offer provider education, product support, clinical collaboration, and access to regenerative biologics with quality and manufacturing documentation. CEO Ian Botham and Chief Medical Officer George C. Shapiro, MD, FACC, framed the expansion as part of a scalable national platform. The company operates from Nova Southeastern University's Center for Collaborative Research in Davie, United States — Florida.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard